Pharmaceutical Executive, Nov 1, 2007

Features

FDA's Approvable Problem

By Walter Armstrong

Approvable letters delay NDAs, cost pharma plenty, and are at an all-time high. Industry says FDA is gun-shy; the agency says it's business as usual. Who's right?

Rx Club Awards: Human Interest

By George Koroneos, Online Content & News Editor

With ads on topics ranging from addiction to disease states, this year's Rx Club Award winners connect creativity with emotion

Step It Up: Branding Roundtable

By Joanna Breitstein

Top pharma brand experts discuss today's issues: safety, compliance, corporate branding, combatting generics, and more.

The Intelligence Diaries

By Leonard M. Fuld

Business intelligence in a time of greater transparency is a whole new ball game. To play it well, be sure to look for surprising insights, expand your list of competitors of interest, and don't let Google be your only guide.

Celebrating Innovation: Prix Galien Photo Gallery

By Joanna Breitstein

Photos from the awards ceremony of the first US Prix Galien, September 25, 2007 in New York City.

Washington Report

More Confidence—or Slower Development?

By Jill Wechsler

FDAAA aims to restore public trust in drug safety regulation but may curb investment in R&D

From the Editor

Chasing Perfection

By Patrick Clinton

A hospital safety expert says it's now possible to completely eliminate certain adverse events. Pharma can't claim the same yet, but is it time for us to start imagining a time when we can "benchmark perfection"?

Column

The Art and Science of Effective Medical Slides

By Tammy Prouty

Most people exhibit characteristics of both visual and verbal learning styles and learn most effectively when information is presented through a combination of the two

From 3-D to Pop-ups: Go Dimensional

By Mike Maguire

In this age of new media, social networking, blogs, and cyber-clutter, it's easy to forget the appeal of the real—of things that you can hold in your hand and engage with physically. But make no mistake, despite all of the high-tech tools available to us, advertising still relies on evoking an emotional response by tickling the human senses.

Reach KOLs Online

By Alain Eudaric, Parexel Medical Communications; Mike Gauthier, eTractions , Mike Gauthier

The impact of high-quality online training tools would be difficult and costly to replicate offline given the dynamic and interactive aspects offered

Thought Leader

Preemption Preview: Q&A with Mark Herrmann, Jones Day

Leadership

Welcome Some Disruption in Your Life

By Sander A. Flaum

We have nothing to fear but the fear of change (with apologies to the wise Franklin D. Roosevelt). But we must get over that if we hope to make a real difference.